Obagi Medical - Best Pharma Stocks of 2007

Company: Obagi Medical
Starting stock price: $9.85
Ending stock price: $18.33
Percent Change: 86.09%

Details: Obagi Medical Products has developed prescription-strength skin health systems focused on preventing and/or improving skin conditions including photodamage, hyperpigmentation (chloasma, melasma, freckles), acne, vulgaris and rosacea. The company went public in October 2007.

Obagi Medical - Best Pharma Stocks of 2007
Read more on

Suggested Articles

The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here: Its crucial Humira follow-up, Rinvoq.

Bristol-Myers Squibb’s takeover of Celgene hasn’t always gone smoothly, but now a once-left-for-dead centerpiece of that deal is ready to launch.

Investors sued Novo Nordisk in Denmark, claiming it misled the public about trouble plaguing its insulin franchise—and demanding $1.75B in damages.